Statistical approach for optimization of external quality assurance (EQA) studies of molecular and serological viral diagnostics

被引:5
|
作者
Rumer, Leonid [1 ,2 ]
Domingo, Cristina [2 ]
Mantke, Oliver Donoso [3 ]
Dobrydneva, Yuliya [4 ,5 ]
Greiner, Matthias [6 ,7 ]
Niedrig, Matthias [2 ]
机构
[1] AJ Innuscreen GmbH, Robert Rossle Str 10, D-13125 Berlin, Germany
[2] Robert Koch Inst, Ctr Biol Threats & Special Pathogens, Berlin, Germany
[3] GBD Gesell Biotechnol Diagnost MbH, Berlin, Germany
[4] Eastern Virginia Med Sch, Dept Physiol Sci, Norfolk, VA 23501 USA
[5] George Washington Sch Med & Hlth Sci, Dept Clin Res & Leadership, Washington, DC USA
[6] BfR Fed Inst Risk Assessment, Dept Exposure, Berlin, Germany
[7] Univ Vet Med Hannover TiHo, Hannover, Germany
关键词
external quality assurance; optimization; statistical approach; viral diagnostics;
D O I
10.1515/cclm-2016-0081
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Management of viral diagnostic quality is based on external quality assurance (EQA), where laboratories involved in diagnostics of a targeted virus are offered to analyze a panel of blinded samples. The utility of EQAs is compromised because of the absence of an approach to EQA design which upfront defines acceptance criteria and associated statistical analysis ensuring fair and consistent interpretation. We offer a rigorous statistically based approach for EQA planning. Instead of a conventional performance characteristic (the score) which is calculated as the sum of the points for correctly identified samples in a blinded test panel, Youden index is used as the performance measure. Unlike the score, Youden index requires an estimate of sensitivity and specificity and incorporates the relationship of these performance parameters. Based on the assumption that the coordinator is a reputable expert of viral diagnostics, the performance of the coordinator's laboratory is defined as a proficiency standard for performance evaluation. The immediate goal of EQA is defined as to obtain a statistically reliable estimation for every laboratory whether its performance meets the proficiency standard, while the overall goal is to match every laboratory to its specific performance level. Dependence of informational capacities of test panel from the panel size and content is quantitatively analyzed and the optimal design and informational capacities of both idealized panels (whose size is not restricted by financial factors) and currently feasible panels are considered. Our approach provides the basis both for rational design of currently feasible EQA test panels and for an increased panel size.
引用
收藏
页码:1589 / 1598
页数:10
相关论文
共 50 条
  • [41] Evolution of autoimmune diagnostics over the past 10 years: lessons learned from the UK NEQAS external quality assessment EQA programs
    Garrafa, Emirena
    Carbone, Teresa
    Infantino, Maria
    Anzivino, Pierluigi
    Boni, Michela
    Ghisellini, Sara
    Muraro, Valentina
    Roselli, Daniele
    Trevisan, Maria Teresa
    Patel, Dina
    Bizzaro, Nicola
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2025,
  • [42] Are Point-of-Care devices suitable for the management of Dengue Virus infections? A comparison with mainframe analysers using External Quality Assurance (EQA) data
    Prasad, Ashley
    Graham, Peter
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2025, 152
  • [43] Quality assurance and optimization studies of light weight PU prosthetic foot
    Application Development Division, CESG, Vikram Sarabhai Space Centre, Trivandrum- 695 022, India
    Trends Biomater. Artif. Organs, 2006, 2 (63-69):
  • [44] First international external quality assessment of molecular diagnostics for Mers-CoV
    Pas, Suzan D.
    Patel, Pranav
    Reusken, Chantal
    Domingo, Cristina
    Corman, Victor M.
    Drosten, Christian
    Dijkman, Ronald
    Thiel, Volker
    Nowotny, Norbert
    Koopmans, Marion P. G.
    Niedrig, Matthias
    JOURNAL OF CLINICAL VIROLOGY, 2015, 69 : 81 - 85
  • [45] Twenty years of experience with the steroid receptor External Quality Assessment program - the paradigm for tumour biomarker EQA studies (Review)
    Geurts-Moespot, J
    Leake, R
    Benraad, TJ
    Sweep, CGJ
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2000, 17 (01) : 13 - 22
  • [46] Sustainability assurance optimization-based approach to energy infrastructure diagnostics in energy systems management
    Hrinchenko, Hanna
    Udovychenko, Viktoriia
    Generalov, Oleksander
    Parfentieva, Olena
    Neskhodovskyi, Illia
    Kopacz, Michal
    POLITYKA ENERGETYCZNA-ENERGY POLICY JOURNAL, 2024, 27 (03): : 109 - 132
  • [47] First Results of an External Quality Assessment (EQA) Scheme for Molecular, Serological and Antigenic Diagnostic Test for SARS-CoV-2 Detection in Lombardy Region (Northern Italy), 2020-2022
    Pasotti, Fabio
    Pellegrinelli, Laura
    Liga, Giuseppa
    Rizzetto, Manuela
    Azzara, Giovanna
    Da Molin, Simona
    Lungu, Oana Livia
    Greco, Silvia
    Galli, Cristina
    Bubba, Laura
    Pariani, Elena
    Corradin, Matteo
    Cereda, Danilo
    Buoro, Sabrina
    DIAGNOSTICS, 2022, 12 (06)
  • [48] External quality assurance (EQA) clinical chemistry program used in conjunction with an empirically derived multirule screen can complement mandated proficiency testing.
    Cembrowski, GS
    Chenard, GC
    CLINICAL CHEMISTRY, 2000, 46 (06) : A71 - A72
  • [49] The World Health Organization Classification of Tumors and External Quality Assurance for Immunohistochemistry and Molecular Pathology
    Cree, Ian A.
    Lokuhetty, Dilani
    Tan, Puay Hoon
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2022, 146 (11) : 1303 - 1307
  • [50] Assessing the Quality of Serological Testing in the COVID-19 Pandemic: Results of a European External Quality Assessment (EQA) Scheme for Anti-SARS-CoV-2 Antibody Detection
    Ast, Volker
    Costina, Victor
    Eichner, Romy
    Bode, Anna
    Aida, Sihem
    Gerhards, Catharina
    Thiaucourt, Margot
    Dobler, Gerhard
    Geilenkeuser, Wolf-Jochen
    Woelfel, Roman
    Neumaier, Michael
    Haselmann, Verena
    JOURNAL OF CLINICAL MICROBIOLOGY, 2021, 59 (09)